Doximity Inc (DOCS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Doximity Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 4 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 20.90 $ — 5% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
8 of 10 Growth gemTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 15.5% passed
- More than 10% revenue growth is expected for the coming year 6.3% failed
- Share count grows by less than 3% a year -2.3% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 62.3% passed
- Gross margin at 40% or higher and without meaningful erosion 89.1% passed
- Goodwill from acquisitions does not grow faster than revenue 7.6% passed
- Net debt below twice EBITDA 738 m net cash passed
- Operating cash flow covers the profits of the last three years 217 m passed
- Return on capital at 15% or higher, or up versus two years ago 22.2% passed
- Insiders hold at least 10% or are net buyers 3.2% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 17.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 19
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 03/31/2027 | 1.43 | 1.28 – 1.54 | 670 | -5.7% | 18 |
| 03/31/2028 | 1.59 | 1.41 – 1.75 | 712 | 11.2% | 15 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.16 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.37 | 55.40 | 169 | 24.60 | 44.60 | 65 | 63 |
| 2025: Q1 | 0.31 | 52.30 | 138 | 17.10 | 45.20 | 99 | 97 |
| 2025: Q2 | 0.27 | 27.60 | 146 | 15.20 | 36.50 | 62 | 60 |
| 2025: Q3 | 0.31 | 40.30 | 169 | 23.20 | 36.80 | 94 | 92 |
| 2025: Q4 | 0.31 | -16.90 | 185 | 9.80 | 33.30 | 61 | 59 |
| 2026: Q1 | 0.10 | -68.10 | 145 | 5.10 | 13.10 | 110 | 107 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 86 | 7 | 8 | 0.04 | 15 | 49 | 87 |
| 2020 | 116 | 22 | 30 | 0.16 | 26 | 1 | 139 |
| 2021 | 207 | 53 | 50 | 0.28 | 83 | 67 | 252 |
| 2022 | 344 | 114 | 155 | 0.81 | 127 | 879 | 991 |
| 2023 | 419 | 125 | 113 | 0.53 | 180 | 966 | 1,137 |
| 2024 | 475 | 164 | 148 | 0.72 | 184 | 901 | 1,079 |
| 2025 | 570 | 228 | 223 | 1.11 | 273 | 1,083 | 1,264 |
| 2026 | 645 | 215 | 196 | 0.98 | 326 | 951 | 1,124 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Doximity, Inc. betreibt eine digitale Plattform für medizinische Fachkräfte in den USA.
| Employees | 880 |
|---|---|
| Headquarters | San Francisco, CA |
| Address | 500 3rd Street, 94107 San Francisco, United States |
| Phone | 650 549 4330 |
| Website | doximity.com |
| IPO Date | 24. Jun 2021 |
| ISIN | US26622P1075 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Jeffrey A. Tangney | Co-Founder, CEO & Chairperson | 1973 |
| Bruno Miranda | Senior Vice President of Engineering | – |
| Joel Davis | Senior Vice President of Product | – |
| Ben Greenberg | Senior VP & GM Commercial Products | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Sitaram Siddharth | Chief Accounting Officer | Sell | 1,732 | 22.02 | 38,139 |
| 15. Jul 2026 | Sitaram Siddharth | Chief Accounting Officer | Other | 4,800 | – | – |
| 13. Jul 2026 | Benjamin Regina M. | Director | Other | 21,314 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.